Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Matyas

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Biorxiv : the Preprint Server for Biology|December 17, 2025
Full-length next-generation sequencing of 11 HLA loci of more than 1000 individuals from clinical cohorts in East and West AfricaYvonne V Rosario, Aviva Geretz, Lakshmi Rani Iyer, et al.
Vaccine|June 2, 2019
Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ)Alicia Cawlfield, Christopher J Genito, Zoltan Beck, et al.
NPJ Vaccines|December 10, 2021
Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaquesPuthupparampil V Scaria, Charles Anderson, Olga Muratova, et al.
NPJ Vaccines|December 14, 2021
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responsesJoshua M Carmen, Shikha Shrivastava, Zhongyan Lu, et al.
NPJ Vaccines|May 5, 2025
Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigensMark D Langowski, Joseph R Francica, Alex L Roederer, et al.
Vaccines|January 21, 2023
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in <i>E. coli</i> Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched VariantsArasu Balasubramaniyam, Emma Ryan, Dallas Brown, et al.
Vaccine|September 2, 2022
First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adultsJack N Hutter, Paul M Robben, Christine Lee, et al.
Journal of Virology|December 13, 2019
Impact of T<sub>h</sub>1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus MacaquesAnil Verma, Brian A Schmidt, Sonny R Elizaldi, et al.
Vaccines|April 3, 2021
Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against MalariaJoseph R Francica, Wei Shi, Gwo-Yu Chuang, et al.
Nature Communications|September 29, 2025
HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaquesMassimiliano Bissa, Mohammad Arif Rahman, Luca Schifanella, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|December 17, 2025
Full-length next-generation sequencing of 11 HLA loci of more than 1000 individuals from clinical cohorts in East and West AfricaYvonne V Rosario, Aviva Geretz, Lakshmi Rani Iyer, et al.
Vaccine|June 2, 2019
Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ)Alicia Cawlfield, Christopher J Genito, Zoltan Beck, et al.
NPJ Vaccines|December 10, 2021
Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaquesPuthupparampil V Scaria, Charles Anderson, Olga Muratova, et al.
NPJ Vaccines|December 14, 2021
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responsesJoshua M Carmen, Shikha Shrivastava, Zhongyan Lu, et al.
NPJ Vaccines|May 5, 2025
Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigensMark D Langowski, Joseph R Francica, Alex L Roederer, et al.
Vaccines|January 21, 2023
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in <i>E. coli</i> Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched VariantsArasu Balasubramaniyam, Emma Ryan, Dallas Brown, et al.
Vaccine|September 2, 2022
First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adultsJack N Hutter, Paul M Robben, Christine Lee, et al.
Journal of Virology|December 13, 2019
Impact of T<sub>h</sub>1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus MacaquesAnil Verma, Brian A Schmidt, Sonny R Elizaldi, et al.
Vaccines|April 3, 2021
Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against MalariaJoseph R Francica, Wei Shi, Gwo-Yu Chuang, et al.
Nature Communications|September 29, 2025
HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaquesMassimiliano Bissa, Mohammad Arif Rahman, Luca Schifanella, et al.
Pageof 12